Suchergebnisse - • Computing Statistical Reproducibility

  1. 1
  2. 2
  3. 3

    Autoren: Jiang Y Zeng B Peng S et al.

    Quelle: Behavior research methods [Behav Res Methods] 2025 Aug 27; Vol. 57 (10), pp. 271. Date of Electronic Publication: 2025 Aug 27.

    Publikationsart: Journal Article

    Info zur Zeitschrift: Publisher: Springer Country of Publication: United States NLM ID: 101244316 Publication Model: Electronic Cited Medium: Internet ISSN: 1554-3528 (Electronic) Linking ISSN: 1554351X NLM ISO Abbreviation: Behav Res Methods Subsets: MEDLINE

  4. 4
  5. 5

    Schlagwörter: ψ–Hamzah, Hamzah Equation, Hamzah Model, Hamzah Vaccine, Hamzah Drug, neonatal asphyxia, perinatal asphyxia, birth complications, neonatal hypoxia, neonatal hypoxaemia, oxidative stress, neonatal mortality, neonatal morbidity, oxygen deprivation, neuronal survival, cardiomyocyte survival, mitochondrial cascade, hypoxic injury, metabolic acidosis, neonatal emergency, neonatal intensive care, oxygen therapy, cerebral protection, cardiac protection, neuroprotection, cardioprotection, hypoxic ischaemia, neonatal medicine, paediatrics, clinical neonatology, newborn survival, neonatal inflammation, cytokine cascade, apoptotic signalling, necrotic signalling, fractal derivative, fractional calculus, complex path integral, fractal pharmacodynamics, fractional pharmacokinetics, PK/PD modelling, advanced PK modelling, advanced PD modelling, nonlinear pharmacology, nonlinear biology, nonlinear systems, stochastic modelling, chaos theory, biological complexity, fractal systems, biomedical mathematics, biophysical modelling, computational medicine, artificial intelligence in medicine, deep learning biology, predictive modelling, cellular dynamics, molecular dynamics, integrative medicine, translational medicine, personalised medicine, precision pharmacology, neonatal drug delivery, neonatal vaccines, neonatal therapeutics, neurovascular protection, mitochondrial reactivation, angiogenesis stimulation, VEGF modulation, HIF-1α stabilisation, protein engineering, peptide engineering, nanomedicine, nanotechnology vaccine, nanotechnology drug, liposomal drug delivery, nanocarrier, PEGylation, PLGA nanoparticle, nanoparticle vaccine, nanoparticle drug, lipid nanoparticles, protein nanoparticle, peptide nanoparticle, drug encapsulation, antigen encapsulation, controlled release, sustained release, drug delivery system, microfluidics, organ-on-a-chip, neonatal simulation, neonatal model, in vitro modelling, in silico modelling, mathematical biology, cellular fractals, mitochondrial fractals, oxygen dynamics, oxygen kinetics, oxygen saturation, oxygen cascade, oxygen distribution, hypoxia adaptation, hypoxia modelling, neonatal brain, neonatal heart, neonatal physiology, neonatal pathology, neonatal pharmacology, neonatal protection, oxygen diffusion, fractal diffusion, diffusion equation, fractional diffusion, stochastic diffusion, Laplace transform, Hamzah transform, spectral analysis, Fourier analysis, wavelet analysis, fractal response, fractal oscillations, cellular fractal response, complex oscillations, fractal immunology, fractal metabolism, nonlinear metabolism, cellular chaos, mitochondrial chaos, drug resistance, genetic mutations, epigenetic regulation, neonatal genetics, neonatal epigenetics, RNA vaccines, mRNA vaccines, DNA vaccines, peptide vaccines, recombinant vaccines, nanoparticle vaccines, immune activation, immune priming, immune resilience, humoral immunity, cellular immunity, T-cell activation, B-cell activation, antibody generation, cytokine signalling, dendritic cell activation, macrophage activation, immune modulation, immunoengineering, vaccine immunology, drug immunology, anti-inflammatory signalling, pro-inflammatory signalling, inflammation control, oxidative damage, ROS inhibition, antioxidant therapy, N-acetyl cysteine, mitochondrial antioxidants, antioxidant peptides, PEG antioxidants, ROS scavenging, mitochondrial repair, neuronal regeneration, cardiac regeneration, synaptic repair, neurovascular coupling, angiogenesis, vascular repair, cerebral perfusion, cardiac perfusion, haemodynamics, neonatal circulation, foetal circulation, placental circulation, transition birth, hypoxic-ischemic encephalopathy, neonatal stroke, perinatal stroke, neonatal seizures, perinatal epilepsy, brain injury prevention, brain tissue protection, cardiomyopathy prevention, perinatal cardiac arrest, sudden infant collapse, neonatal interventions, neonatal therapies, neonatal resuscitation, neonatal protocols, neonatal intensive medicine, neonatal care units, global neonatal health, WHO neonatal strategy, UNICEF neonatal strategy, global vaccine policy, global drug policy, intellectual property, Berne Convention, WIPO patent, pharmacological patent, vaccine patent, nanomedicine patent, IP protection, biomedical innovation, translational science, clinical trials, Phase I trials, Phase II trials, Phase III trials, Phase IV trials, neonatal clinical trial, neonatal ethics, neonatal safety, biomedical ethics, neonatal regulations, GMP standards, cleanroom standards, ISO 5 cleanroom, ISO 7 cleanroom, HEPA filter, controlled temperature, controlled humidity, lyophilisation, freeze-drying stability, protein stability, nanoparticle stability, vaccine stability, drug stability, advanced stability testing, accelerated stability testing, quality control, QC analysis, DLS analysis, zeta potential analysis, HPLC analysis, qPCR testing, ELISA testing, immunoassay testing, cytotoxicity testing, MTT assay, in vitro testing, in vivo testing, computational testing, simulation validation, scenario modelling, stress testing, reproducibility testing, clinical reproducibility, statistical reproducibility, extreme scenarios, 100×100 scenarios, global simulation, trillion scenarios, computational robustness, algorithmic robustness, high-performance computing, biomedical AI, medical AI, AI drug discovery, AI vaccine discovery, AI therapeutics, machine learning biology, quantum biology, quantum pharmacology, integrative fractals, fractal pharmacology, fractal biology, complex biology, systemic modelling, cross-scale modelling, multi-scale modelling, organ-level modelling, cellular-level modelling, subcellular modelling, genomic modelling, proteomic modelling, metabolomic modelling, systems biology, omics biology, computational immunology, computational pharmacology, advanced therapeutics, regenerative medicine, advanced biotechnology, futuristic medicine, neonatal rescue therapy, neonatal regenerative therapy, crisis medicine, extreme scenario medicine, neonatal future medicine, neonatal advanced care, global neonatal medicine, universal neonatal protocol, neonatal anti-asphyxia vaccine, neonatal anti-asphyxia drug, ψ–Hamzah vaccine, ψ–Hamzah drug, ψ–Hamzah medicine, ψ–Hamzah therapy, ψ–Hamzah model validation, ψ–Hamzah universal application, ψ–Hamzah genetic adaptation, ψ–Hamzah resistance modelling, ψ–Hamzah advanced pharmacology, ψ–Hamzah computational pipeline, ψ–Hamzah simulation pipeline, ψ–Hamzah efficacy 99.99%, ψ–Hamzah safety 0%, ψ–Hamzah perfection model, ψ–Hamzah world-class science, ψ–Hamzah intellectual property, ψ–Hamzah clinical translation, ψ–Hamzah neonatal survival, ψ–Hamzah excellence, ψ–Hamzah biomedical architecture, ψ–Hamzah ultimate validation, ψ–Hamzah paradigm shift, ψ–Hamzah scientific revolution

  6. 6

    Autoren: Meng X Xu G

    Quelle: The British journal of mathematical and statistical psychology [Br J Math Stat Psychol] 2025 Feb; Vol. 78 (1), pp. 190-224. Date of Electronic Publication: 2024 Oct 10.

    Publikationsart: Journal Article

    Info zur Zeitschrift: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0004047 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2044-8317 (Electronic) Linking ISSN: 00071102 NLM ISO Abbreviation: Br J Math Stat Psychol Subsets: MEDLINE

  7. 7

    Quelle: Suicide & life-threatening behavior [Suicide Life Threat Behav] 2025 Oct; Vol. 55 (5), pp. e70057.

    Publikationsart: Journal Article

    Info zur Zeitschrift: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7608054 Publication Model: Print Cited Medium: Internet ISSN: 1943-278X (Electronic) Linking ISSN: 03630234 NLM ISO Abbreviation: Suicide Life Threat Behav Subsets: MEDLINE

  8. 8

    Autoren: Arimoro OI Lix LM Patten SB et al.

    Quelle: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation [Qual Life Res] 2025 Oct; Vol. 34 (10), pp. 2797-2808. Date of Electronic Publication: 2025 Jul 18.

    Publikationsart: Journal Article

    Info zur Zeitschrift: Publisher: Springer Netherlands Country of Publication: Netherlands NLM ID: 9210257 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-2649 (Electronic) Linking ISSN: 09629343 NLM ISO Abbreviation: Qual Life Res Subsets: MEDLINE

  9. 9

    Autoren: Zhu YA Xu J Wang D et al.

    Quelle: The British journal of mathematical and statistical psychology [Br J Math Stat Psychol] 2025 May; Vol. 78 (2), pp. 617-646. Date of Electronic Publication: 2024 Dec 15.

    Publikationsart: Journal Article

    Info zur Zeitschrift: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0004047 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2044-8317 (Electronic) Linking ISSN: 00071102 NLM ISO Abbreviation: Br J Math Stat Psychol Subsets: MEDLINE

  10. 10

    Quelle: Journal of traumatic stress [J Trauma Stress] 2025 Apr; Vol. 38 (2), pp. 247-258. Date of Electronic Publication: 2024 Dec 29.

    Publikationsart: Journal Article

    Info zur Zeitschrift: Publisher: Wiley Country of Publication: United States NLM ID: 8809259 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-6598 (Electronic) Linking ISSN: 08949867 NLM ISO Abbreviation: J Trauma Stress Subsets: MEDLINE

  11. 11
  12. 12

    Schlagwörter: ψ–Hamzah, Hamzah Equation, fractional calculus, fractal dynamics, nonlinear immunology, severe dengue, dengue shock syndrome, DSS, SIR model, SEIR model, ψ–Hamzah vaccine, ψ–Hamzah drug, anti-cancer vaccine, anti-cancer medicine, PK/PD modelling, pharmacokinetics, pharmacodynamics, cell regeneration index, host survival, cytokine index, viremia, immune modulation, fractional derivative, fractional immunotherapy, fractal pharmacology, multiscale modelling, host-virus interaction, immune response modelling, in vitro simulation, in vivo simulation, in silico validation, advanced vaccine design, Hamzah fractional inactivation, dengue viral antigens, NS1 protein, E protein, fractional immune modulator, β–Hamzah nanoparticles, liposome carrier, PLA/PLGA copolymer, biodegradable polymer, PBS buffer, magnesium ions, calcium ions, stabilising sugars, mannitol, sucrose, cellular fraction stimulator, Thiomersal ψ–Hamzah, sterile diluent, nanoparticle stability, nanomedicine, immune cell activation, antigen delivery, antigen protection, drug resistance prediction, genetic mutation modelling, multidimensional simulation, systemic modelling, shock prevention, host cell survival, virology, immunopathology, molecular immunology, fractal immunopathogenesis, computational immunology, cellular immunity, T-cell activation, B-cell activation, antibody titres, immune memory, pharmacological safety, toxicity minimisation, immuno-oncology, viral suppression, inflammation control, cytokine storm suppression, blood pressure modelling, organ function modelling, cardiovascular stability, hepatic function, renal protection, clinical immunology, vaccine pharmacodynamics, therapeutic vaccines, broad-spectrum antivirals, host-directed therapy, adaptive immunity, innate immunity, fractional kinetics, fractional epidemiology, epidemic prediction, outbreak modelling, computational biology, mathematical epidemiology, nonlinear dynamics, advanced biophysics, nanotechnology in vaccines, drug nanocarriers, controlled release, immune engineering, molecular engineering, biosystem modelling, fractional-order ODEs, fractional PDEs, mathematical biology, systems biology, bioinformatics, computational drug design, immunopharmacology, regenerative biology, regenerative medicine, advanced biostatistics, stochastic modelling, deterministic modelling, dynamical systems, complex systems, hybrid modelling, clinical trial simulation, personalised medicine, targeted therapy, paediatric immunology, neonatal immunotherapy, resistant cancers, viral oncology, epidemic containment, therapeutic simulation, drug distribution modelling, one-compartment model, multi-compartment model, dose optimisation, immune kinetics, receptor binding modelling, ligand interaction, PK/PD hybrid model, toxicity assessment, drug clearance, drug absorption, bioavailability, dose-response relationship, therapeutic index, immune checkpoint modulation, checkpoint inhibitors, cellular apoptosis, immune evasion, host-pathogen interaction, molecular docking simulation, structural bioinformatics, vaccine efficacy prediction, adaptive dosing, precision pharmacology, immune stimulation, macrophage activation, dendritic cell response, antigen processing, antigen presentation, immune adjuvants, epitope design, protein stability, protein folding, viral inactivation, fractional virology, fractional immunotherapy models, fractal immunology, stability testing, environmental simulation, humidity conditions, temperature control, pH stability, light sensitivity, nanoparticle degradation, quality assurance, reproducibility, experimental validation, in silico reproducibility, statistical reproducibility, cross-validation, data integration, bioinformatics pipelines, artificial intelligence in drug design, machine learning in immunology, deep learning pharmacology, big data pharmacology, quantum biology, quantum pharmacology, multi-scale integration, hierarchical modelling, nonlocal operators, fractional operators, fractional Laplacian, non-integer dynamics, chaos modelling, chaotic immunology, nonlinear control, biological control systems, immunological stability, vaccine safety, therapeutic safety, systems pharmacology, global health, pandemic preparedness, outbreak response, epidemic control, health systems modelling, virological suppression, immune modulation dynamics, therapeutic modelling, antiviral nanomedicine, anti-inflammatory nanomedicine, tissue regeneration, wound healing, fibrosis prevention, multi-drug resistance, antimicrobial resistance, antiviral resistance, vaccine development pipelines, vaccine scalability, industrial vaccine production, cold-chain stability, pharmaceutical stability, dosage form optimisation, clinical immunopharmacology, mathematical modelling of disease, disease progression modelling, viral kinetics, viral load reduction, viral clearance, immune balance, immunological tolerance, immunological homeostasis, haemodynamic stability, blood flow modelling, microcirculation, endothelial function, capillary leakage, vascular modelling, haemorrhagic fever modelling, viral haemorrhagic fever, arbovirus modelling, flavivirus modelling, zoonotic disease modelling, dengue fever modelling, chikungunya modelling, Zika modelling, yellow fever modelling, vector-borne disease modelling, mosquito-borne disease modelling, epidemiological transition, predictive epidemiology, computational vaccinology, structural vaccinology, vaccine nanotechnology, vaccine optimisation, therapeutic efficacy, therapeutic outcome prediction, adverse effect modelling, adverse event prevention, zero-toxicity design, host protection, viral inhibition, immune equilibrium, epigenetic modelling, epigenetic response, molecular signalling, intracellular dynamics, extracellular signalling, immunological cascades, cytokine networks, interleukin modelling, interferon response, TNF-alpha suppression, IL-6 suppression, NF-kB modulation, STAT pathway modulation, signal transduction, receptor-ligand binding, gene expression dynamics, transcriptional regulation, translational regulation, proteomic modelling, metabolomic modelling, immunometabolism, metabolic regulation, systems vaccinology, computational oncology, tumour immunology, tumour suppression, tumour regression, metastasis inhibition, angiogenesis inhibition, tumour microenvironment, immune microenvironment, immunoediting, immune evasion pathways, checkpoint blockade, CAR-T extension, NK cell activation, immunotherapy design, synthetic biology in immunology, genome editing in vaccine design, CRISPR vaccine design, mRNA vaccines, DNA vaccines, peptide vaccines, protein subunit vaccines, viral vector vaccines, live-attenuated vaccines, inactivated vaccines, nanoparticle vaccines, conjugate vaccines, next-generation vaccines, universal vaccines, personalised vaccines, combination therapy, synergistic therapy, adjuvant therapy, therapeutic synergy, fractional dose modelling, booster dose prediction, immunisation schedules, long-term immunity, herd immunity, immune landscape, immune profiling, clinical modelling, therapeutic trial simulation, AI-driven vaccine design, AI-driven pharmacology, predictive toxicology, computational toxicology, digital immunology, digital twin modelling, immune digital twin, patient-specific simulation, biophysical simulation, molecular simulation, agent-based modelling, cellular automata modelling, stochastic cell modelling, Monte Carlo pharmacology, numerical immunology, finite element pharmacology, high-performance computing in pharmacology, exascale simulation, parallel pharmacology simulation, distributed pharmacology, cloud pharmacology, bioinformatics integration, computational efficiency, reproducible science, open science pharmacology, intellectual property protection, biomedical innovation, translational medicine, bench-to-bedside modelling, integrative pharmacology, cutting-edge vaccinology, advanced drug engineering, immunological precision, biomedical ethics, ethical pharmacology, global deployment, universal accessibility, equitable vaccine distribution, humanitarian pharmacology, pandemic resilience, sustainable vaccine design, sustainable drug design, biotechnological innovation, futuristic pharmacology, advanced immunotherapy, ψ–Hamzah validation, ψ–Hamzah intellectual property, Seyed Rasoul Jalali, Hamzah scientific framework, Hamzah paradigm, advanced computational vaccinology, next-generation immunopharmacology, universal immunotherapy

  13. 13

    Quelle: JAMA [JAMA] 2020 Jul 21; Vol. 324 (3), pp. 235-236.

    Publikationsart: Journal Article; Research Support, Non-U.S. Gov't

    Info zur Zeitschrift: Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE

  14. 14

    Quelle: Research synthesis methods [Res Synth Methods] 2024 Nov; Vol. 15 (6), pp. 1094-1110. Date of Electronic Publication: 2024 Sep 25.

    Publikationsart: Journal Article; Comparative Study

    Info zur Zeitschrift: Publisher: Cambridge University Press Country of Publication: England NLM ID: 101543738 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1759-2887 (Electronic) Linking ISSN: 17592879 NLM ISO Abbreviation: Res Synth Methods Subsets: MEDLINE

  15. 15

    Autoren: Becker BJ Zhang Q

    Quelle: The British journal of mathematical and statistical psychology [Br J Math Stat Psychol] 2024 Nov; Vol. 77 (3), pp. 395-428. Date of Electronic Publication: 2024 Apr 26.

    Publikationsart: Journal Article

    Info zur Zeitschrift: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0004047 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2044-8317 (Electronic) Linking ISSN: 00071102 NLM ISO Abbreviation: Br J Math Stat Psychol Subsets: MEDLINE

  16. 16

    Autoren: Schulz M Kramer M Kuss O et al.

    Quelle: Research synthesis methods [Res Synth Methods] 2024 Nov; Vol. 15 (6), pp. 978-987. Date of Electronic Publication: 2024 Aug 13.

    Publikationsart: Journal Article

    Info zur Zeitschrift: Publisher: Cambridge University Press Country of Publication: England NLM ID: 101543738 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1759-2887 (Electronic) Linking ISSN: 17592879 NLM ISO Abbreviation: Res Synth Methods Subsets: MEDLINE

  17. 17

    Quelle: Biometrical journal. Biometrische Zeitschrift [Biom J] 2024 Mar; Vol. 66 (2), pp. e2300060.

    Publikationsart: Journal Article; Review

    Info zur Zeitschrift: Publisher: Wiley-VCH Verlag GmbH & Co. KGaA Country of Publication: Germany NLM ID: 7708048 Publication Model: Print Cited Medium: Internet ISSN: 1521-4036 (Electronic) Linking ISSN: 03233847 NLM ISO Abbreviation: Biom J Subsets: MEDLINE

  18. 18

    Autoren: Hartner I Brooks WS Sinha T et al.

    Quelle: Anatomical sciences education [Anat Sci Educ] 2025 Aug; Vol. 18 (8), pp. 774-785. Date of Electronic Publication: 2025 Jan 04.

    Publikationsart: Journal Article

    Info zur Zeitschrift: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101392205 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1935-9780 (Electronic) Linking ISSN: 19359772 NLM ISO Abbreviation: Anat Sci Educ Subsets: MEDLINE

  19. 19

    Quelle: Eating and weight disorders : EWD [Eat Weight Disord] 2025 Jul 17; Vol. 30 (1), pp. 55. Date of Electronic Publication: 2025 Jul 17.

    Publikationsart: Journal Article

    Info zur Zeitschrift: Publisher: Springer Country of Publication: Germany NLM ID: 9707113 Publication Model: Electronic Cited Medium: Internet ISSN: 1590-1262 (Electronic) Linking ISSN: 11244909 NLM ISO Abbreviation: Eat Weight Disord Subsets: MEDLINE

  20. 20